I.A. Kurnikova
FOROSA IN THE THERAPY OF CALCIUM AND PHOSPHORUS METABOLISM DISORDERS IN ENDOCRINOLOGICAL PATIENTS
|
№5 / 2014
|
I.A. Baranova
IDENTIFICATION OF PERSONS WITH OSTEOPOROTIC FRACTURES AND RISK OF THEIR DEVELOPMENT
|
№18 / 2013
|
A.V. Ledina, V.N. Prilepskaya
PREVENTION AND TREATMENT OF OSTEOPOROSIS IN PREGNANT WOMEN
|
№s5-13 / 2013
|
S. S. Apetov, S.Yu. Kalinchenko
THE ROLE OF SEX HORMONES, ANDROGENS AND ESTROGENS, IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS IN MEN AND WOMEN
|
№s5-13 / 2013
|
V.N. Shishkova
THE USE OF VITAMIN D IN ELDERLY PATIENTS OR POSTMENOPAUSAL WOMEN: THE UPDATE OF RECOMMENDATIONS OF EUROPEAN SOCIETY ON CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO, 2013)
|
№s5-13 / 2013
|
N.A. Shostak, A.A. Kondrashov, A.A. Muradyants, V.S. Shemenkova
OSTEOPOROSIS IN MEN: APPROACHES TO THERAPY FROM THE PERSPECTIVE OF CURRENT POSITION
|
№s5-13 / 2013
|
I.A. Baranova
OSTEOPOROSIS IN PRACTICE OF PULMONOLOGIST
|
№s5-13 / 2013
|
N.Yu. Karpova, M.A. Rashid, N.A. Shostak, T.V. Kazakova
CARDIOVASCULAR DISEASES AND OSTEOPOROSIS
|
№s5-13 / 2013
|
V. P. Smetnik, A.A.Smetnik
ESTROGENS AND BONE TISSUE
|
№12 / 2013
|
V. N. Shishkova
OSTEOPOROSIS IN NEUROLOGICAL: PRACTICE: FOCUS ON THE SPINE
|
№9 / 2013
|
O.B. Ershova, A.V. Nazarova
BISPHOSPHONATES - DURATION OF USE IN OSTEOPOROSIS, REASONABILITY AND SAFETY
|
№7 / 2013
|
L.A.Ruyatkina, A.V.Lomova, D. S. Ruyatkin
Bone Status In Type 2 Diabetes Mellitus
|
№5 / 2013
|